State of the Pharmaceutical Sales Industry
Posted by Hunter on 15 Jan 2012 | Tagged as: Uncategorized
There is a major upheaval within the pharmaceutical industry. We are in what I would call the post “COLD WAR” of the industry. Around 10 years ago with the launch of a number of blockbuster products like Lipitor and Celebrex, the companies embarked on an arms race of a sort. Through out this time they started hiring massive numbers of pharmaceutical sales people and marketing people to promote these products.
The thought was if one company was going to have one sales representative in the territory selling a product, a competitive company would hire two sales reps per territory. Then the race was on. A company would get three sales reps then four and so on and so forth. This had massive impact on the industry. In some places there would be eight sales people per territory. It was absurd and expensive. In fact, I read a report that if you had a breadbasket of the 50 biggest pharmaceutical stocks from the year 1999 to now 2012, as a shareholder you would have made zero return on these stocks. This is profound because this was during some of the most lucrative blockbuster years the industry has seen. Selling products like Celebrex, Lipitor and numerous other blockbusters and not a penny was returned to investors. All this is in a turn around phase because this cannot continue.
Jobs in this industry are highly coveted. They are out there and you can make some great money in a very rewarding career. In my mind, the industry is going to go back to the old days where you have one rep per territory with a couple of good pharmaceutical products and it is old style selling. Reading my book can help you get that career. www.pharmacareerguide.com
Hunter Davis

Looking for a top-paying career in pharma- ceutical sales?